“Le Conseguenze Sulla Spesa Farmaceutica Pubblica Di Un Nuovo Inibitore Di Pompa Protonica: Esomeprazolo”. Farmeconomia. Health Economics and Therapeutic Pathways 3, no. 1 (March 15, 2002): 5–14. Accessed December 29, 2025. https://journals.seedstm.com/index.php/FE/article/view/739.